| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $54.9M | — | -17.9% |
| R&D Expense | $12.4M | — | -44.0% |
| SG&A Expense | $17.7M | — | -23.7% |
| Operating Income | -$17.4M | — | +42.7% |
| Pre-tax Income | -$10.1M | — | +40.7% |
| Income Tax | $217K | — | -61.8% |
| Net Income | -$10.9M | — | +41.8% |
| EPS (Basic) | -$0.66 | — | +44.5% |
| EPS (Diluted) | -$0.66 | — | +44.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $179.2M | -1.7% | -19.4% |
| Accounts Receivable | $57.1M | +14.9% | -20.7% |
| Inventory | $1.1M | -3.3% | -54.6% |
| Current Assets | $259.1M | +5.0% | -16.8% |
| Total Assets | $326.0M | +0.7% | -22.3% |
| Current Liabilities | $83.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$983K | — | +96.1% |
| Capital Expenditures | $5K | — | -44.4% |
| Investing Cash Flow | -$2.8M | — | -114.4% |
| Financing Cash Flow | $303K | — | -44.2% |
| Free Cash Flow | -$988K | — | +96.1% |
| -21.5% |
| Total Liabilities | $85.8M | +13.0% | -24.5% |
| Stockholders' Equity | $227.3M | -3.5% | -22.7% |